Table E.1.
Country | Overall mg/PCU | 3rd‐ and 4th‐generation cephalosporins | All quinolones (proportion of fluoroquinolones vs all quinolones) | Polymyxins |
---|---|---|---|---|
Austria | 56.3 | 0.2 | 0.5 (100%) | 1.6 |
Belgium | 158.3 | 0.5 | 2.0 (54%) | 3.4 |
Bulgaria | 82.9 | 0.1 | 1.8 (100%) | 0.5 |
Croatia | 114.8 | 0.1 | 4.4 (84%) | 4.0 |
Cyprus | 391.5 | 0.8 | 1.5 (62%) | 11.2 |
Czech Republic | 79.6 | 0.4 | 1.8 (99%) | 1.1 |
Denmark | 44.2 | 0.02 | 0.7 (1%) | 0.4 |
Estonia | 77.1 | 0.6 | 1.6 (100%) | 3.1 |
Finland | 22.3 | 0.02 | 0.2 (100%) | 0 |
France | 107.0 | 0.3 | 1.4 (45%) | 7.1 |
Germany | 149.3 | 0.4 | 1.4 (100%) | 12.2 |
Hungary | 193.1 | 0.3 | 9.4 (97%) | 7.1 |
Iceland | 5.2 | 0.01 | <0.01 (100%) | 0 |
Ireland | 47.6 | 0.1 | 0.4 (100%) | 0.1 |
Italy | 332.4 | 0.4 | 7.1 (44%) | 29.4 |
Latvia | 36.7 | 0.4 | 1.6 (99%) | 0.8 |
Lithuania | 35.5 | 0.2 | 4.0 (79%) | 0.1 |
Luxembourg | 40.9 | 0.6 | 0.7 (95%) | 2.5 |
Netherlands | 68.4 | < 0.01 | 1.2 (11%) | 0.5 |
Norway | 3.1 | < 0.01 | 0.1 (11%) | 0 |
Poland | 140.8 | 0.2 | 9.1 (99%) | 5.0 |
Portugal | 201.6 | 0.4 | 11.6 (98%) | 17.6 |
Romania | 109.1 | 0.05 | 5.5 (96%) | 6.5 |
Slovakia | 65.9 | 0.5 | 4.2 (99%) | 1.5 |
Slovenia | 33.4 | 0.1 | 4.0 (100%) | 0.1 |
Spain | 418.8 | 0.3 | 10.8 (92%) | 36.1 |
Sweden | 11.5 | < 0.01 | 0.03 (99%) | 0.1 |
Switzerland | 56.9 | 0.2 | 0.5 (100%) | 1.0 |
United Kingdom | 62.1 | 0.2 | 0.4 (100%) | 0.1 |